September 29, 2014 / 2:03 PM / 3 years ago

BUZZ-Alimera Sciences Inc: FDA approves eye implant

1 Min Read

** Drug developer's shares up 11.5 pct at $5.49

** U.S. FDA, on Friday, approved Alimera's eye implant to treat diabetic macular edema, a condition that causes vision impairment due to swelling of the retina

** Company says implant, Iluvien, expected to be available in the United States in early 2015

** Company licensed implant from pSivida Corp in February 2005. pSivida to receive milestone payment of $25 million following approval

** Up to Friday's close, Alimera stock had gained about 5 pct this year

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below